David C. Kaslow

David C. Kaslow is Vice President, Essential Medicines, and Head, PATH’s Center for Vaccine Innovation and Access (CVIA), supporting product development and introduction of vaccines and drugs. He has 30+ years of research and development experience in product development that spans work in government, biotech, big pharma and non-profit. Before joining PATH in 2012 as Director of PATH Malaria Vaccine Initiative, he was Vice President and Head of Vaccines Project Leadership and Management at Merck Research Laboratories.

From 2001-2006, he was Chief Scientific Officer at Vical and for two years prior to that he was Senior Director of Virus and Cell Biology and Head of Vaccine Research and Technology at Merck Research Laboratories. From 1986-1999, he served in the US Public Health Service at the National Institute of Allergy and Infectious Diseases (NIAID), where he was Head, Malaria Vaccine Section and founder of the Malaria Vaccine Development Unit. David received a Biochemistry Bachelor of Sciences from the University of California, Davis, and a MD degree from the University of California, San Francisco.